Stockreport

Nuvation Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]

Nuvation Bio Inc. Class A  (NUVB) 
PDF ROS1-positive (ROS1+) non-small cell lung cancer (NSCLC); Prescription Drug User Fee Act (PDUFA) goal date of June 23, 2025 Innovent Biologics' commercialization of ta [Read more]